Inbal Hazan-Halevy The Center of Nanoscience and Nanotechnology Tel Aviv University Biography Publications Institution JoVE Articles Inbal Hazan-Halevy has not added a biography. If you are Inbal Hazan-Halevy and would like to personalize this page please email our Author Liaison for assistance. Publications Harnessing RNAi-based Nanomedicines for Therapeutic Gene Silencing in B-cell Malignancies Proceedings of the National Academy of Sciences of the United States of America. Jan, 2016 | Pubmed ID: 26699502 Metabolism Pathways in Chronic Lymphocytic Leukemia Leukemia & Lymphoma. Apr, 2016 | Pubmed ID: 26643954 Cell-specific Uptake of Mantle Cell Lymphoma-derived Exosomes by Malignant and Non-malignant B-lymphocytes Cancer Letters. Aug, 2015 | Pubmed ID: 25933830 STAT3-activated GM-CSFRα Translocates to the Nucleus and Protects CLL Cells from Apoptosis Molecular Cancer Research : MCR. Sep, 2014 | Pubmed ID: 24836891 Stimulation of the B-cell Receptor Activates the JAK2/STAT3 Signaling Pathway in Chronic Lymphocytic Leukemia Cells Blood. Jun, 2014 | Pubmed ID: 24778152 Personalized Medicine in CLL: Current Status and Future Perspectives Cancer Letters. Sep, 2014 | Pubmed ID: 23879961 Divergence in CD19-mediated Signaling Unfolds Intraclonal Diversity in Chronic Lymphocytic Leukemia, Which Correlates with Disease Progression Journal of Immunology (Baltimore, Md. : 1950). Jan, 2013 | Pubmed ID: 23241880 Increased CD39 Expression on CD4(+) T Lymphocytes Has Clinical and Prognostic Significance in Chronic Lymphocytic Leukemia Annals of Hematology. Aug, 2012 | Pubmed ID: 22349724 Reciprocal Changes in Regulatory T Cells and Th17 Helper Cells Induced by Exercise in Patients with Chronic Lymphocytic Leukemia Leukemia & Lymphoma. Sep, 2012 | Pubmed ID: 22242820 The Cytokine Midkine and Its Receptor RPTPζ Regulate B Cell Survival in a Pathway Induced by CD74 Journal of Immunology (Baltimore, Md. : 1950). Jan, 2012 | Pubmed ID: 22140262 Activation of CD44, a Receptor for Extracellular Matrix Components, Protects Chronic Lymphocytic Leukemia Cells from Spontaneous and Drug Induced Apoptosis Through MCL-1 Leukemia & Lymphoma. Sep, 2011 | Pubmed ID: 21649540 STAT-3 Activates NF-kappaB in Chronic Lymphocytic Leukemia Cells Molecular Cancer Research : MCR. Apr, 2011 | Pubmed ID: 21364020 The Synthetic Heat Shock Protein 90 (Hsp90) Inhibitor EC141 Induces Degradation of Bcr-Abl P190 Protein and Apoptosis of Ph-positive Acute Lymphoblastic Leukemia Cells Investigational New Drugs. Dec, 2011 | Pubmed ID: 20533075 Kit Inhibitor APcK110 Extends Survival in an AML Xenograft Mouse Model Investigational New Drugs. Oct, 2011 | Pubmed ID: 20517635 STAT3 is Constitutively Phosphorylated on Serine 727 Residues, Binds DNA, and Activates Transcription in CLL Cells Blood. Apr, 2010 | Pubmed ID: 20154216 Kit Inhibitor APcK110 Induces Apoptosis and Inhibits Proliferation of Acute Myeloid Leukemia Cells Cancer Research. May, 2009 | Pubmed ID: 19383925 The Effects of Natural Antioxidants from Tomato Extract in Treated but Uncontrolled Hypertensive Patients Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. Apr, 2009 | Pubmed ID: 19052855 WP1066 Disrupts Janus Kinase-2 and Induces Caspase-dependent Apoptosis in Acute Myelogenous Leukemia Cells Cancer Research. Dec, 2007 | Pubmed ID: 18056455 Stimulation of NADPH Oxidase by Angiotensin II in Human Neutrophils is Mediated by ERK, P38 MAP-kinase and Cytosolic Phospholipase A2 Journal of Hypertension. Jun, 2005 | Pubmed ID: 15894894 Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome Uri Rozovski1, Inbal Hazan-Halevy2, George Calin3, David Harris4, Ping Li4, Zhiming Liu4, Michael J. Keating4, Zeev Estrov4 1Division of Hematology, Davidoff Cancer Center, Rabin Medical Center, 2The Center of Nanoscience and Nanotechnology, Tel Aviv University, 3Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 4Department of Leukemia, The University of Texas MD Anderson Cancer Center JoVE 53300 Bioengineering
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome Uri Rozovski1, Inbal Hazan-Halevy2, George Calin3, David Harris4, Ping Li4, Zhiming Liu4, Michael J. Keating4, Zeev Estrov4 1Division of Hematology, Davidoff Cancer Center, Rabin Medical Center, 2The Center of Nanoscience and Nanotechnology, Tel Aviv University, 3Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 4Department of Leukemia, The University of Texas MD Anderson Cancer Center JoVE 53300 Bioengineering
